Skip to main content

Table 3 List of malignancies diagnosed before or during active surveillance in the institute for medical screening

From: An impact of lipid profile and lipid lowering drugs on ≥70 year olds of an upper socioeconomic class: a retrospective cohort study

Malignancy category 1st malignancy diagnosed pre-IMS surveillance 1st malignancy diagnosed during IMS surveillance Second and additional malignancies diagnosed during IMS surveillance
Men Women Total Men Women Total Men Women Totalb
Breast 0 22 22 1 39 40 1 4 5
Lung 2 1 3 15 3 18 1 1 2
Gastrointestinal* 16 5 21 40 4 44 8 0 8
Genitourinary 49 3 52 147 5 152 33 1 34
Hematologic§ 12 3 15 56 14 70 5 7 12
Gynecologicǁ 0 6 6 0 4 4 0 2 2
Melanoma 18 13 31 55 9 64 14 1 15
Other 8 3 11 9 5 14 5 5 10
  1. *Gastrointestinal- colorectal, pancreas, biliary, stomach, esophagus and liver; Genitourinary- prostate, kidney, urothelial, bladder, testicular; §Hematologic- leukemia, Hodgkin’s and non-Hodgkin’s lymphoma, multiple myeloma and myelodysplastic syndrome; ǁGynecologic- ovarian, uterine, cervical; Other- head and neck, brain, thyroid, sarcoma, skin cancer requiring systemic therapy other than melanoma, or primary unknown; †15 cases of second malignancy were diagnosed prior to the IMS surveillance: 2 breast, 2 gastrointestinal, 3 genitourinary, 2 hematologic, 1 gynecologic, 4 melanoma and 1 other (advanced squamous cell carcinoma)